原发性胆汁性肝硬化危险因素的研究进展
Research Progress on Risk Factors for Primary Biliary Cirrhosis
DOI: 10.12677/ACM.2023.1371610, PDF,   
作者: 张瑶瑶, 雷 芯*：延安大学附属医院消化内科，陕西 延安
关键词: 原发性胆汁性肝硬化；遗传；吸烟；感染；异生物素；维生素D；BMI；Primary Biliary Cirrhosis； Heredity； Smoking； Infection； Xenobiotin； Vitamin D； BMI
摘要: 原发性胆汁性肝硬化(PBC)是一种成年人慢性进行性胆汁淤积性肝病，以肝内进行性非化脓性小胆管破坏伴门静脉炎症和肝纤维化为特点，最终可进展为肝硬化和肝衰竭，是肝移植的主要适应症之一。本文将对PBC发生的危险因素做统一综述。
Abstract: Primary biliary cirrhosis (PBC) is a chronic progressive cholestatic liver disease in adults, charac-terized by progressive nonpurulent destruction of small bile ducts in the liver with portal vein in-flammation and fibrosis, which can eventually progress to cirrhosis and liver failure, and is one of the main indications for liver transplantation. This article will provide a unified review of risk fac-tors for the occurrence of PBC.
文章引用：张瑶瑶, 雷芯. 原发性胆汁性肝硬化危险因素的研究进展[J]. 临床医学进展, 2023, 13(7): 11517-11522. https://doi.org/10.12677/ACM.2023.1371610

参考文献

[1] Lindor, K.D., Gershwin, M.E., Poupon, R., Kaplan, M., Bergasa, N.V. and Heathcote, E.J. (2009) Primary Biliary Cir-rhosis. Hepatology, 50, 291-308. [Google Scholar] [CrossRef] [PubMed]
[2] Corpechot, C., Gaouar, F., Chrétien, Y., et al. (2012) Smoking as an Independent Risk Factor of Liver Fibrosis in Primary Biliary Cirrhosis. Journal of Hepatol-ogy, 56, 218-524. [Google Scholar] [CrossRef] [PubMed]
[3] Mantaka, A., Koulentaki, M., Samonakis, D., et al. (2018) Association of Smoking with Liver Fibrosis and Mortality in Primary Biliary Cholangitis. European Journal of Gastroenterology & Hepatology, 30, 1461-1469. [Google Scholar] [CrossRef] 
[4] Wijarnpreecha, K., Werlang, M., Panjawatanan, P., et al. (2019) Association between Smoking and Risk of Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal and Liver Diseases, 28, 197-203. [Google Scholar] [CrossRef] [PubMed]
[5] Burroughs, A.K., Rosenstein, I.J., Epstein, O., Hamilton-Miller, J.M., Brumfitt, W. and Sherlock, S. (1984) Bacteriuria and Primary Biliary Cirrhosis. Gut, 25, 133-137. [Google Scholar] [CrossRef] [PubMed]
[6] Prince, M.I., Ducker, S.J. and James, O.F. (2010) Case-Control Studies of Risk Factors for Primary Biliary Cirrhosis in Two United Kingdom Populations. Gut, 59, 508-512. [Google Scholar] [CrossRef] [PubMed]
[7] Gershwin, M.E., Selmi, C., Worman, H.J., et al. (2005) Risk Factors and Comorbidities in Primary Biliary Cirrhosis: A Controlled Interview-Based Study of 1032 Pa-tients. Hepatology, 42, 1194-1202. [Google Scholar] [CrossRef] [PubMed]
[8] Tanaka, A., Leung, P.S.C. and Gersh-win, M.E. (2019) Pathogen Infections and Primary Biliary Cholangitis. Clinical and Experimental Immunology, 195, 25-34. [Google Scholar] [CrossRef] [PubMed]
[9] Nilsson, H.O., Taneera, J., Castedal, M., et al. (2000) Identification of Helicobacter pylori and other Helicobacter species by PCR, Hybridization and Partial DNA Sequencing in Human Liver Samples from Patients with Primary Sclerosing Cholangitis or Primary Biliary Cirrhosis. Journal of Clinical Mi-crobiology, 38, 1072-1076. [Google Scholar] [CrossRef] 
[10] Ljungh, A., Nilsson, H.O., Wadström, T., et al. (2005) Microbes as Trigger for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Digestive and Liver Disease, 37, 803-804. [Google Scholar] [CrossRef] [PubMed]
[11] Tanaka, A., Leung, P.S. and Gershwink, M.E. (2018) En-vironmental Basis of Primary Biliary Cholangitis. E xperimental Biology and Medicine, 243, 184-189. [Google Scholar] [CrossRef] [PubMed]
[12] Tanaka, A., Leung, P.S.C. and Gershwin, M.E. (2018) Evolution of Our Understanding of PBC. Best Practice & Research Clinical Gastroenterology, 34-35, 3-9. [Google Scholar] [CrossRef] [PubMed]
[13] Xu, H., Wu, Z., Feng, F., Li, Y. and Zhang, S. (2022) Low Vitamin D Concentrations and BMI Are Causal Factors for Primary Biliary Cholangitis: A Mendelian Randomization Study. Frontiers in Immunology, 13, Article 1055953. [Google Scholar] [CrossRef] [PubMed]
[14] Ebadi, M., Ip, S., Lytvyak, E., et al. (2022) Vitamin D Is Asso-ciated with Clinical Outcomes in Patients with Primary Biliary Cholangitis. Nutrients, 14, Article 878. [Google Scholar] [CrossRef] [PubMed]
[15] vinh quốc Lương, K. and Hoàng Nguyễn, L.T., (2013) The Role of Vita-min D in Primary Biliary Cirrhosis: Possible Genetic and Cell Signaling Mechanisms. Gastroenterology Research and Practice, 2013, Article ID: 602321. [Google Scholar] [CrossRef] [PubMed]
[16] Lazaridis, K.N., Juran, B.D., Boe, G.M., et al. (2007) Increased Preva-lence of Antimitochondrial Antibodies in First-Degree Relatives of Patients with Primary Biliary Cirrhosis. Hepatology, 46, 785-792. [Google Scholar] [CrossRef] [PubMed]
[17] Selmi, C., Mayo, M.J., Bach, N., et al. (2004) Primary Biliary Cirrhosis in Monozygotic and Dizygotic Twins: Genetics, Epigenetics and Environment. Gastroenterology, 127, 485-492. [Google Scholar] [CrossRef] [PubMed]
[18] Juran, B.D. and Lazaridis, K.N. (2010) Update on the Genetics and Genomics of PBC. Journal of Autoimmunity, 35, 181-187. [Google Scholar] [CrossRef] [PubMed]
[19] Lammert, C., Nguyen, D.L., Juran, B.D., Schlicht, E., Larson, J.J., Atkinson, E.J. and Lazaridis, K.N. (2013) Questionnaire Based Assessment of Risk Factors for Primary Biliarycirrhosis. Digestive and Liver Disease, 45, 589-594. [Google Scholar] [CrossRef] [PubMed]
[20] Menon, K.V., Angulo, P., Weston, S., Dickson, E.R. and Lindor, K.D. (2001) Bone Disease in Primary Biliary Cirrhosis: Independent Indicators and Rate of Progression. Journal of Hepatology, 35, 316-323. [Google Scholar] [CrossRef] 
[21] Alvaro, D., Invernizzi, P., Onori, P., Franchitto, A., De San-tis, A., Crosignani, A., Sferra, R., Ginanni-Corradini, S., Mancino, M.G., Maggioni, M., Attili, A.F., Podda, M. and Gaudio, E. (2004) Estrogen Receptors in Cholangiocytes and the Progression of Primary Biliary Cirrhosis. Journal of Hepatology, 41, 905-912. [Google Scholar] [CrossRef] [PubMed]
[22] Menon, K.V., Angulo, P., Boe, G.M. and Lindor, K.D. (2003) Safety and Efficacy of Estrogen Therapy in Preventing Bone Loss in Primary Biliary Cirrhosis. The American Journal of Gastroenterology, 98, 889-892.
[23] Parikh-Patel, A., Gold, E., Utts, J. and Gershwin, M.E. (2002) The Association between Gravidity and Primary Biliary Cirrhosis. Annals of Epidemiology, 12, 264-272. [Google Scholar] [CrossRef] 
[24] Milona, A., Owen, B.M., Cobbold, J.F., Willemsen, E.C., Cox, I.J., Boudjelal, M., Cairns, W., Schoonjans, K., Taylor-Robinson, S.D., Klomp, L.W., Parker, M.G., White, R., van Mil, S.W. and Williamson, C. (2010) Raised Hepatic Bile Acid Concentrations during Pregnancy in Mice Are Associated with Reduced Farnesoid X Receptor Function. Hepatology, 52, 1341-1349. [Google Scholar] [CrossRef] [PubMed]
[25] Sun, Y., Haapanen, K., Li, B., Zhang, W., Van de Water, J. and Gershwin, M.E. (2015) Women and Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology, 48, 285-300. [Google Scholar] [CrossRef] [PubMed]
[26] Corpechot, C., Chrétien, Y., Chazouillères, O. and Poupon, R. (2010) Demographic, Lifestyle, Medical and Familial Factors Associated with Primary Biliary Cirrhosis. The Journal of Hepatology, 53, 162-169. [Google Scholar] [CrossRef] [PubMed]

为你推荐